Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Appointed director
ADIAL PHARMACEUTICALS, INC. (ADIL) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 8-K Quarterly results
08/23/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "ADIAL PHARMACEUTICALS, INC. PRESS RELEASE DATED AUGUST 23, 2023"
08/21/2023 8-K Quarterly results
Docs: "PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON AUGUST 21, 2023"
08/18/2023 8-K Quarterly results
08/04/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "State of Delaware Secretary of State Division of Corporations Delivered 08:03 AM 08/03/2023 FILED 08:03 AM 08/03/2023 SR 20233153666 - File Number 6439279 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION",
"Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’ s Minimum Bid Price Requirement and Reduce the Public Float Common Stock Will Begin Trading on Split-Adjusted Basis on August 7, 2023"
07/10/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
06/09/2023 8-K Investor presentation
Docs: "ADIAL PHARMACEUTICALS, INC. INVESTOR PRESENTATION DATED JUNE 9, 2023"
06/02/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "PURCHASE AGREEMENT PURCHASE AGREEMENT , dated as of May 31, 2023, by and between ADIAL PHARMACEUTICALS, INC., a Delaware corporation , and ALUMNI CAPITAL LP, a Delaware limited partnership . RECITALS"
05/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
05/12/2023 8-K Quarterly results
Docs: "PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MAY 12, 2023"
05/10/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "RE: Notice of Option Exercise",
"Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’ s Assets and Business"
04/13/2023 8-K Quarterly results
03/31/2023 8-K Quarterly results
Docs: "Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business Update"
03/21/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Master Services Agreement between Adial Pharmaceuticals, Inc. and The Keswick Group, LLC",
"Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder"
03/07/2023 8-K Investor presentation
Docs: "ADIAL PHARMACEUTICALS, INC. PRESS RELEASE DATED MARCH 6, 2023",
"ADIAL PHARMACEUTICALS, INC. INVESTOR PRESENTATION DATED MARCH 7, 2023"
03/02/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
02/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Adial Pharmaceuticals Announces Closing of $0.75 Million At-The-Market Registered Direct Offering"
02/24/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF PLACEMENT AGENT WARRANT",
"OPINION OF BLANK ROME LLP",
"FORM OF SECURITIES PURCHASE AGREEMENT",
"Placement Agency Agreement",
"Form of Voting Agreement",
"Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering"
02/01/2023 8-K Quarterly results
11/15/2022 8-K Quarterly results
10/13/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT NO. 4 TO THE ADIAL PHARMACEUTICALS, INC. 2017 EQUITY INCENTIVE PLAN"
09/26/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Adial Pharmaceuticals Announces Positive In Vivo Data for Purnovate’ s PNV-5030 as a Potential Treatment for Chronic Pain"
09/14/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
09/13/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL AMENDMENT TO CONSULTING AGREEMENT"
09/06/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Adial Pharmaceuticals Announces Positive In-Vivo Non-clinical Data with Purnovate’ s PNV-6005 as a Potential Treatment for Ulcerative Colitis"
09/02/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
08/23/2022 8-K Appointed a new director
Docs: "AMENDMENT TO EMPLOYMENT AGREEMENT",
"AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment dated as of the 22nd day of August, 2022 amends the Employment Agreement, dated July 31, 2018, as amended , by and between Adial Pharmaceuticals, Inc. , and William B. Stilley, III . Capitalized terms used herein without definition shall have the meanings assigned in the Agreement. WHEREAS, Executive and the Corporation desire to amend the Employment Agreement. NOW THEREFORE, for the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree to amend the Employment Agreement as follows: 1. Amendments 1.1 The first sentence of Section 2.2. of the Employment Agreement is hereby deleted in its entirety and replaced with the following: “Beg..."
08/16/2022 8-K Quarterly results
07/20/2022 8-K Quarterly results
06/27/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ADIAL PHARMACEUTICALS ANNOUNCES DATABASE LOCK FOR THE ONWARD™ PHASE 3 CLINICAL TRIAL"
05/16/2022 8-K Quarterly results
02/28/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial S...
02/14/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF PRE-FUNDED WARRANT",
"FORM OF COMMON STOCK PURCHASE WARRANT",
"OPINION OF BLANK ROME LLP",
"FORM OF SECURITIES PURCHASE AGREEMENT",
"PLACEMENT AGENCY AGREEMENT",
"Crescendo Communications, LLC David Waldman"
02/09/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy